ATBECHDEDKESFRGBGRITLILUNLSE..PTIE..................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0684823A119951206EP94909745.01994022219950922enenen1993002051719930222US1995120619954919951206199549

A61K 9/ 00 A I

A61K 31/ 407 A I

A61K 31/ 41 A I

A61K 31/ 415 A I

A61K 31/ 4162 A I

A61K 31/ 437 A I

A61K 31/ 495 A I

A61K 31/ 4985 A I

A61K 31/ 55 A I

A61K 38/ 16 A I

A61K 38/ 49 A I

A61K 45/ 06 A I

A61P 7/ 02 A I

C07D 471/ 04 A I

C07D 487/ 04 A I

enFIBRINOGEN RECEPTOR ANTAGONISTSfrANTAGONISTES DES RECEPTEURS DE FIBRINOGENEdeFIBRINOGENREZEPTORANTAGONISTENMERCK & CO. INC.126, East Lincoln Avenue P.O. Box 2000Rahway New Jersey 07065-0900USCLAREMON, David Alan1508 Aidenn Lair RoadMaple Glen, PA 19002USBALDWIN, John J.621 Gypsy Hill CircleGwynedd Valley, PA 19437USLIVERTON, Nigel786 Sharon LaneHarleysville, PA 19438USASKEW, Ben513 Lamplighter WayLansdale, PA 19446USCole, William GwynEuropean Patent Department Merck & Co., Inc. Terlings Park Eastwick RoadHarlow Essex CM20 2QRGBATBECHDEDKESFRGBGRIEITLILUNLPTSEUS199400188119940222enWO199401898119940901199420